ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Xtl Biopharmaceuticals (XTLB) Technical (Analysis) Reports Xtl Biopharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Xtl Biopharmaceuticals (XTLB)

Technical Analysis Report for NASDAQ stock XTLB Xtl Biopharmaceuticals. Dated: 31 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock XTLB Xtl Biopharmaceuticals then click here. or read Experts views on Xtl Biopharmaceuticals or Forecast & share price targets of Xtl Biopharmaceuticals

Xtl Biopharmaceuticals Opened at 2.50 and Closed at: 2.82, which is -1.06% of previous session's close. It moved within a range of 2.50 and 2.82
The session was a Bullish session with an average volume of 1700, which is -117.65% of previous session's volumes.

    Support for tomorrow is 2.66 and resistance for tomorrow is 2.98
    These support and resistance points are valid for the first 5-15 minutes charts

    Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

    Support for tomorrow's hourly charts is 2.61, 2.39 resistance for tomorrow's hourly charts is 2.93, 3.03

    10 Day SMA for Xtl Biopharmaceuticals (XTLB) is 2.91 and stock is trading below these levels. This is not a good sign for its short term trend

    20 Day SMA for Xtl Biopharmaceuticals (XTLB) is 2.9 and the stock is trading below these levels. This is not a good sign for its mid term trend

    50 Day SMA for Xtl Biopharmaceuticals (XTLB) is 2.62 and the stock is trading above these levels. This is a good sign for its mid to long term trend

    100 Day SMA is 2.47 and the stock is trading above these levels. This is a good sign for its long term trend

    200 Day SMA Xtl Biopharmaceuticals is 1.68 and stock is trading above these levels. This is a good sign for its long term trend

    20 DMA of Xtl Biopharmaceuticals is at 2.9 and 200 DMA is at 1.68, while 50 DMA and 100 DMA are at 2.62 and 2.47 respectively

    Xtl Biopharmaceuticals (XTLB) moving average of 20 SMA is at 2.9 and 20 EMA is at 2.85

    Xtl Biopharmaceuticals (XTLB) moving average of 50 SMA is at 2.62 and 50 EMA is at 2.69

    Xtl Biopharmaceuticals (XTLB) moving average of 100 SMA is at 2.47 and 100 EMA is at 2.37

    Xtl Biopharmaceuticals (XTLB) moving average of 200 SMA is at 1.68 and 200 EMA is at 2.08

    Dentsply Sirona has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Dentsply Sirona, about 15.05% more returns!

    Xtl Biopharmaceuticals has performed better than Tonix Pharmaceuticals in short term. Holding Xtl Biopharmaceuticals could be a better choice for now!

    Xtl Biopharmaceuticals has performed better than Sutro Biopharma in short term. Holding Xtl Biopharmaceuticals could be a better choice for now!

    Scynexis Inc has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Scynexis Inc, about 10.14% more returns!

    Repligen Corporation has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Repligen Corporation, about 6.21% more returns!

    Proqr Therapeutics has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Proqr Therapeutics, about 8.98% more returns!

    Kiniksa Pharmaceuticals has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Kiniksa Pharmaceuticals, about 15.8% more returns!

    Anavex Life has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Anavex Life, about 6.85% more returns!

    Biolife Solutions has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Biolife Solutions, about 17.36% more returns!

    Xtl Biopharmaceuticals has performed better than Catalyst Biosciences in short term. Holding Xtl Biopharmaceuticals could be a better choice for now!

    Heron Therapeutics has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Heron Therapeutics, about 21.65% more returns!

    Immucell Corporation has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Immucell Corporation, about 13.78% more returns!

    Xtl Biopharmaceuticals has performed better than Iradimed Corporation in short term. Holding Xtl Biopharmaceuticals could be a better choice for now!

    Xtl Biopharmaceuticals Technical analysis of indicators

    Price action analysis of Xtl Biopharmaceuticals (XTLB) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

    ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.

    MACD generated a SELL signal for Xtl Biopharmaceuticals in short term but the sell signal is initial and weak.

    Xtl Biopharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.

    Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down

    CCI has generated a SELL signal for Xtl Biopharmaceuticals in short term and SELL signal is strong!

    RSI is generating a BUY signal in short term and the buying is gaining momentum.

    MRSI is in positive zone. This is a BUY zone

    Although the stock is in the BUY zone, but buying might be slowing down

    Stock of Xtl Biopharmaceuticals is picking up selling momentum according to indicator.

    Volume based indicators are showing selling momentum.

    Volume Weighted Averaged Price (VWAP) for short term is 2.91 and Xtl Biopharmaceuticals XTLB stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

    People seem to be coming out and selling the Xtl Biopharmaceuticals XTLB stock. Volume based technical analysis of Xtl Biopharmaceuticals XTLB stock is negative.

    Xtl Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive

    Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

    Tomorrow's Predictions

    You should also read Tomorrow's Movement Predictions for NASDAQ stock XTLB Xtl Biopharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

    And XTLB Experts View which covers a lot of information including buying and selling signals

    XTLB future forecast & share price targets

    You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Xtl Biopharmaceuticals or View Candle Stick Charts here

    Chart Xtl Biopharmaceuticals (XTLB)  Technical (Analysis) Reports Xtl Biopharmaceuticals [

    Videos related to: Xtl Biopharmaceuticals (XTLB) Technical (Analysis) Reports Xtl Biopharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

    Hindi Basics How To Trade In FnO Futures Options Stock Market

    Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

    Xtl Biopharmaceuticals (XTLB)  Technical (Analysis) Reports Xtl Biopharmaceuticals [

     

    Back to top